Skip to main content
Premium Trial:

Request an Annual Quote

New Products: OGT's CytoSure Interpret Software


Oxford Gene Technology this week launched a new version of its CytoSure Interpret Software.

Oxford, UK-based OGT provides CytoSure Interpret with all purchases of its CytoSure microarray products. The tool supports the analysis of array comparative genomic hybridization data.

The latest version of CytoSure Interpret includes a feature called automatic aberration classification that enables users to configure the software to automatically perform an initial classification of any detected copy number variant, accelerating analysis and standardizing the interpretation process.

CytoSure Interpret Software also allows simultaneous access to sample and experiment information across a network, enabling multiple laboratories access to a central database. When IT infrastructures do not support this, the software provides features for exporting sample and experiment information into other databases, OGT said.

In addition to its free text phenotype field, users can now simplify and normalize the phenotype description process via a Human Phenotype Ontology Phenotype Selector window.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.